Skip to main content

Table 1 Main results from individual patients

From: Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series

  Pt #1 Pt #2 Pt #3 Pt #4
Age (years) 47 59 37 58
SOFA score at ICU admission 13 13 13 14
Time spent under ECMO (days) 8 6 5 8
Time spent under MV (days) 13 18 8 21
Day of influenza A (H1N1)pdm09 virus detection 0 0 0 1
Day of first negative influenza A(H1N1)pdm09 virus 15 20 12 13
Length of zanamivir therapy (days) 11 17 11 11
Superinfection by MDR
 Ab Yes No No Yes
 CR-Kp Yes Yes Yes No
 Treatment colistin+ ceftazidime/avibactam colistin+ meropenem colistin+ meropenem+ ertapenem colistin+ tigecycline+ rifampicin
  1. SOFA Sequential Organ Failure Assessment, ICU Intensive Care Unit, ECMO Extra-Corporeal Membrane Oxygenation, MV Mechanical Ventilation, MDR Multi-Drug Resistant bacteria, Ab Acinetobacter baumannii, CR-Kp Carbapenem Resistant Klebsiella pneumonia